AUTUM CALDWELL: Open Payments
NPI 1396093647 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,208 in 86 payments from 20 companies in 2025. Trend: 2023 $2,232 · 2024 $1,578 · 2025 $2,208
Food & beverage: $2,107Education: $101
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $366 |
| Janssen Biotech, Inc. | 6 | $243 |
| Novartis Pharmaceuticals Corporation | 8 | $226 |
| ABBVIE INC. | 6 | $206 |
| Lilly USA, LLC | 9 | $190 |
| PFIZER INC. | 9 | $189 |
| GENZYME CORPORATION | 3 | $152 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $128 |
| Arcutis Biotherapeutics, Inc. | 1 | $91 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
Products named: DUPIXENT, TREMFYA, TALTZ, LITFULO, RINVOQ, Zoryve, SKYRIZI, Sotyktu.
Industry payments across OK — which companies pay providers there.
